- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01915563
Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure
Phase 2 Study of 60-min Rest After Successful Spontaneous Breathing Trial Before Extubation as a Tool for Reduction Post-extubation Failure.
Study Overview
Detailed Description
Intubation and mechanical ventilation are related with several complications. This increased the risk of mortality of intensive care patients. So, we always look for an early extubation when patients are recovered for the trigger disease. In spite of standardized manoeuvres to decided readiness for extubation these are not quite good because it has been described a failure extubation rate of 5% and a reintubation rate of 15%. Furthermore several risk factors has been associated with a major failure rate:>65 years old, congestive cardiac insufficiency, chronic obstructive pulmonary disease, APACHE II >12 the extubation day, BMI >30, ineffective cough, a lot of bronchial secretions (as the need for >2 endotracheal suctioning in the last 8h before extubation), failure of a previous SBT,alterations of high respiratory tract or intubation for more than 7 days.Patients without any of these factors risk has an extubation failure rate of 10% while if any of these are present extubation failure increase to 30%.
The most used technique as a weaning trial is named spontaneous breathing trial (SBT). Some physiological aspects suggest that breathing through an endotracheal tube could be a really effort trial. So our hypothesis is that a period of rest after SBT and before extubation could reduce the extubation failure rate.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Terrassa, Barcelona, Spain, 08221
- Hospitales: Mutua de Terrassa,Médico-quirúrgico Jaen, Morales Messeguer, General de Albacete, Lorca, Málaga, Santiago, General de Catalunya, Joan XXIII Tarragona, La Fe-Valencia, Bellvitge, Moises Broggi, Mateu Orfila, Reina Sofia, Severo-Ochoa, Delfos
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients ventilated for more than 12h and ready to perform a SBT
Exclusion Criteria:
- patients under 18 years old,
- tracheostomy,
- excessive bronchial secretions,
- agitation,
- hypercapnia during SBT and not resuscitation orders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: SBT and extubation
After a SBT patients will be extubated as usual
|
|
Experimental: SBT and rest 60 min before extubation
After SBT patients will be reconnected to mechanical ventilation during 60 min before extubation
|
After a SBT patients will be extubated as usual or reconnected to mechanical ventilation for 60 min before extubation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With Extubation Failure
Time Frame: 48 hours
|
Development of predefined criteria of respiratory insufficiency within 48 hours after scheduled extubation
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
ICU Mortality
Time Frame: up to 3 months
|
up to 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Fernandez Rafael, MD, PhD, Althaia Xarxa Assistencial Universitària de Manresa
- Study Director: Fernandez Maria del Mar, MD, PhD, Hospital Universitari Mutua de Terrassa
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SBT Spain 001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weaning Failure
-
National Cancer Institute, EgyptCompletedWeaning Failure | Successful WeaningEgypt
-
Ain Shams UniversityUnknown
-
Beni-Suef UniversityUnknown
-
Ain Shams UniversityCompleted
-
Cairo UniversityCompleted
-
Hôpital d'enfants Béchir-HamzaUnknownWeaning FailureTunisia
-
Hospital Israelita Albert EinsteinCompletedWeaning FailureBrazil
-
Qingdao UniversityNot yet recruiting
-
Evangelismos HospitalNot yet recruiting
Clinical Trials on REST
-
University of VirginiaUniversity of Colorado, DenverRecruiting
-
Riphah International UniversityCompletedMusculoskeletal PainPakistan
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...CompletedAnorexia Nervosa | Constitutional LeannessFrance
-
AMCGNot yet recruitingCoronary Artery DiseaseKorea, Republic of
-
Colorado State UniversityCompletedChronic InsomniaUnited States
-
National Taiwan Normal UniversityCompletedEating Behavior | Food RewardTaiwan
-
Rambam Health Care CampusCompletedVocal Cord Dysfunction | Vocal Fold PolypIsrael
-
Mayo ClinicCompletedCancerUnited States
-
Central Hospital, Nancy, FranceUnknownPatient Position | Attenuation Artifact | Myocardial TomoscintigraphyFrance
-
Science and Research Centre KoperUniversity of Trieste; University of Padova; University of Pavia; University of... and other collaboratorsCompletedMuscular AtrophySlovenia